Cargando…

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report

BACKGROUND: Congenital portosystemic shunt is an infrequent abnormal connection between the portal vascular system and the systemic circulation. Portosystemic shunts are common findings in patients with cirrhosis, causing gastroesophageal varices, hepatic encephalopathy, and others. However, there i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagao, Yoshihiro, Toshida, Katsuya, Morinaga, Akinari, Tomiyama, Takahiro, Kosai, Yukiko, Shimagaki, Tomonari, Tomino, Takahiro, Wang, Huanlin, Kurihara, Takeshi, Toshima, Takeo, Morita, Kazutoyo, Itoh, Shinji, Harada, Noboru, Yoshizumi, Tomoharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537393/ https://www.ncbi.nlm.nih.gov/pubmed/36201092 http://dx.doi.org/10.1186/s40792-022-01533-3

Ejemplares similares

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2022)

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2022)

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma
por: Toshida, Katsuya, et al.
Publicado: (2022)

Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report
por: Tomiyama, Takahiro, et al.
Publicado: (2021)

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2021)

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection
por: Itoh, Shinji, et al.
Publicado: (2022)

Which is better to use “body weight” or “standard liver weight”, for predicting small‐for‐size graft syndrome after living donor liver transplantation?
por: Toshima, Takeo, et al.
Publicado: (2020)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021)

Association between Sarcopenia and Omega-3 Polyunsaturated Fatty Acid in Patients with Hepatocellular Carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
por: Yugawa, Kyohei, et al.
Publicado: (2020)

A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients
por: Tomiyama, Takahiro, et al.
Publicado: (2023)

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
por: Iseda, Norifumi, et al.
Publicado: (2018)

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
por: Itoh, Shinji, et al.
Publicado: (2021)

Curative surgery for multiple hepatocellular carcinomas after lenvatinib plus transarterial chemoembolization: a case report
por: Shiraishi, Jin, et al.
Publicado: (2023)

The authors’ reply: Indispensable discrepancy between predicted graft “volume” and actual graft “weight” in clinical practice in living‐donor liver transplantation
por: Toshima, Takeo, et al.
Publicado: (2021)

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

A new scoring system with simple preoperative parameters as predictors of early recurrence of pancreatic ductal adenocarcinoma
por: Shimagaki, Tomonari, et al.
Publicado: (2023)

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
por: Yonemura, Yusuke, et al.
Publicado: (2020)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Congenital portosystemic venous shunt
por: Papamichail, M., et al.
Publicado: (2017)

An Adult Case of Congenital Extrahepatic Portosystemic Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration
por: Tanaka, Hironori, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Liver resection with right hepatic vein reconstruction using the internal jugular vein: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2016)

The Role of Percutaneous Transjugular Portosystemic Shunts
por: Gordon, Roy L.
Publicado: (1992)

Congenital Portosystemic Shunt: Our Experience
por: Timpanaro, Tiziana, et al.
Publicado: (2015)

Asymptomatic Congenital Intrahepatic Portosystemic Shunt
por: Brown, Karen M., et al.
Publicado: (2016)

Congenital intrahepatic portosystemic venous shunt
por: Kashgari, Amna, et al.
Publicado: (2020)

Presentation of Congenital Portosystemic Shunts in Children
por: Bahadori, Atessa, et al.
Publicado: (2022)

Status of congenital extrahepatic portosystemic shunt
por: Zeng, Pan, et al.
Publicado: (2022)

Successful embolisation of intrahepatic portosystemic venous shunt using AMPLATZER Vascular Plug II
por: Tomiyama, Akiko, et al.
Publicado: (2016)

Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013)

Aberrant Gene Expression in Dogs with Portosystemic Shunts
por: van Steenbeek, Frank G., et al.
Publicado: (2013)

Acquired Hepatocerebral Degeneration in the Absence of Portosystemic Shunting
por: Caranci, Giovanni, et al.
Publicado: (2019)

The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)

Hepatic encephalopathy due to extrahepatic portosystemic shunt
por: Sazumi, Yosuke, et al.
Publicado: (2020)

Laparoscopic portosystemic shunt attenuation in two cats
por: Izzo, Francesca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sm9lgf8he9vvrdgob0vji3f593